What Is Sermorelin and How Does It Compare to Ipamorelin?
Sermorelin (GHRH 1-29 NH₂) is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It was FDA-approved as Geref for pediatric GH deficiency diagnosis and treatment, and later used off-label for age-related GH decline. Sermorelin stimulates the pituitary to produce and release natural GH pulses — preserving the body's own GH regulation mechanisms. Ipamorelin (a GHRP, GH-releasing peptide) works through a different receptor — the ghrelin receptor — to trigger a selective, clean GH pulse with minimal effect on cortisol or prolactin (Raun K et al., Eur J Endocrinol, 1998, PMID: 9703375). CalcMyPeptide provides free reconstitution calculators for sermorelin, ipamorelin, and all GH secretagogues.
Mechanism Comparison: Sermorelin, Ipamorelin, and MK-677
| Property | Sermorelin (GHRH) | Ipamorelin (GHRP) | MK-677 (Ibutamoren) |
|---|---|---|---|
| Receptor | GHRH receptor | Ghrelin receptor | Ghrelin receptor |
| Route | Injectable (SubQ) | Injectable (SubQ) | Oral tablet/capsule |
| Half-life | ~11 minutes | ~2 hours | ~24 hours |
| GH pulse | Natural pulsatile | Clean pulsatile | Continuous (non-pulsatile) |
| Cortisol effect | None | None | Mild increase |
| Prolactin effect | None | None | Mild increase |
| IGF-1 increase | Moderate | Moderate | High (24h elevation) |
| Feedback respected | Yes | Yes | Yes (but continuous) |
| FDA status | Was approved (Geref) | Not approved | Not approved |
The fundamental difference: sermorelin + ipamorelin (injected) produce pulsatile GH release that mimics natural physiology. MK-677 (oral) produces 24-hour continuous GH elevation that disrupts the natural pulsatile pattern.
Sermorelin + Ipamorelin Stack: The Synergistic Combination
Sermorelin (GHRH analog) and ipamorelin (ghrelin receptor agonist) work at two different receptor systems that are synergistic in the pituitary. GHRH (sermorelin) occupies GHRH receptors on somatotroph cells, increasing intracellular cAMP and GH synthesis. Ghrelin receptor agonism (ipamorelin) stimulates GH release through a separate calcium-dependent pathway. When both receptors are activated simultaneously, GH output is significantly greater than either alone — this is the basis of the popular sermorelin + ipamorelin or CJC-1295 + ipamorelin stack (Teichman SL et al., J Clin Endocrinol Metab, 2006, PMID: 16352683).
A typical combination protocol: 100 mcg sermorelin + 100-200 mcg ipamorelin, injected subcutaneously 30-60 minutes before sleep (GH peaks naturally during stage 3-4 sleep; timing injection to align with this window produces the greatest GH pulse amplitude).
Reconstitution: For each peptide, use 2 mL BAC water per 2 mg vial → 1 mg/mL concentration. On a U-100 syringe, 10 units = 100 mcg. Use CalcMyPeptide for exact calculations for your specific vial concentration.
MK-677 (Ibutamoren): Pros, Cons, and Risk Profile
MK-677 is an orally active ghrelin receptor agonist — not a true peptide (it is a non-peptide small molecule), but functionally equivalent to injectable GHRPs. Its oral activity is its primary appeal. Murphy MG et al. (J Clin Endocrinol Metab, 1998, PMID: 9506738) showed MK-677 reverses diet-induced catabolism and increases GH/IGF-1 levels in healthy subjects. Two-year data (Nass R et al., J Clin Endocrinol Metab, 2008, PMID: 18544658) showed sustained IGF-1 elevation and improved body composition in elderly patients.
MK-677 risks vs injectable alternatives:
• 24-hour GH elevation vs physiological pulses: injectable secretagogues produce brief GH pulses; MK-677 elevates GH for 24 hours continuously, which is associated with greater insulin resistance, water retention, and potentially joint pain
• Higher IGF-1 elevation: continuous stimulation elevates IGF-1 more than pulsatile injection, amplifying both benefits (muscle, recovery) and risks (insulin resistance)
• Appetite stimulation: MK-677 strongly stimulates appetite (ghrelin pathway effect) — useful for bulking, counterproductive for fat loss
• No injection required: significant convenience advantage
Dosing Protocols Compared
| Protocol | Dose | Timing | Notes |
|---|---|---|---|
| Sermorelin | 100-200 mcg | Before sleep | Best natural GH amplification |
| Ipamorelin | 100-300 mcg | Before sleep | Stack with sermorelin |
| Sermorelin + Ipamorelin | 100 mcg each | Before sleep | Synergistic; most physiological |
| MK-677 | 12.5-25 mg | Any time (daily) | Oral convenience; continuous GH |
| CJC-1295 no DAC + Ipamorelin | 100 mcg + 100-200 mcg | Before sleep | Alternative GHRH; slightly longer half-life than sermorelin |
Cycle recommendations: Injectable secretagogues — 12-16 weeks on, 4-8 weeks off. MK-677 — some protocols use continuously; others cycle 3-6 months on, 1-2 months off to prevent receptor desensitization.
Which Is Better for Fat Loss: Sermorelin/Ipamorelin or MK-677?
For fat loss specifically, the injectable stack (sermorelin/ipamorelin or CJC-1295/ipamorelin) is generally preferred over MK-677. Reasons: (1) Injectable pulsatile GH does not significantly impair insulin sensitivity; MK-677 continuous GH elevation increases insulin resistance, counteracting fat loss. (2) MK-677 strongly stimulates appetite (ghrelin pathway); appetite increase counteracts caloric deficit needed for fat loss. (3) Injectable protocols produce cleaner fat oxidation without the appetite and insulin resistance headwinds.
For muscle preservation / anti-aging / sleep quality: MK-677's 24-hour efficacy and oral convenience may outweigh the insulin sensitivity tradeoff for some users, particularly those primarily interested in muscle maintenance, sleep quality improvement (MK-677 increases GH/IGF-1 during sleep phases), and cognition.
How Does Sermorelin Preserve the GH Feedback Axis?
Sermorelin stimulates the pituitary to produce GH through its own regulatory machinery — it does not bypass somatostatin feedback. After a GHRH-induced GH pulse, rising GH triggers somatostatin release from the hypothalamus, which then suppresses further GH release. This negative feedback is preserved with sermorelin (and ipamorelin), maintaining the natural rhythm of GH secretion. Exogenous GH (hGH injection) bypasses this entirely — the pituitary detects high GH and down-regulates its own production, ultimately suppressing the axis with prolonged use. This is why secretagogues are considered more physiological and lower risk for axis suppression than exogenous GH.
What Is the Best GH Secretagogue for Anti-Aging?
For anti-aging purposes specifically — improving sleep quality, body composition, skin quality, and cognitive function — the evidence supports the CJC-1295 (no DAC) + ipamorelin combination as the most evidence-supported injectable protocol. CJC-1295 without DAC has a half-life similar to sermorelin (~30 min active GHRH effect) but produces a slightly stronger GH pulse in comparative data (Teichman SL et al., 2006). Combined with ipamorelin's clean GHRP effect, the combination produces the physiological benefits of GH optimization with minimal side effects. For oral convenience, MK-677 has the longest human evidence data across two-year studies. Use the CalcMyPeptide reconstitution calculator to get exact dosing units for your vials.